Drug
Angiotensin-Converting Enzyme Inhibitors
Angiotensin-Converting Enzyme Inhibitors is a pharmaceutical drug with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_3
1
25%
Ph phase_4
1
25%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)
Trials by Status
completed375%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)
NCT00000558
terminated
Effect of Caldine® on Renal Function in Balanced Hypertension
NCT02240641
completednot_applicable
Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation
NCT00224809
completedphase_4
Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline
NCT00126516
Clinical Trials (4)
Showing 4 of 4 trials
NCT00000558Phase 3
Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)
NCT02240641
Effect of Caldine® on Renal Function in Balanced Hypertension
NCT00224809Not Applicable
Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation
NCT00126516Phase 4
Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4